Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1356567rdf:typepubmed:Citationlld:pubmed
pubmed-article:1356567lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:1356567lifeskim:mentionsumls-concept:C0032912lld:lifeskim
pubmed-article:1356567lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:1356567lifeskim:mentionsumls-concept:C0232105lld:lifeskim
pubmed-article:1356567lifeskim:mentionsumls-concept:C2003941lld:lifeskim
pubmed-article:1356567lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:1356567lifeskim:mentionsumls-concept:C0231491lld:lifeskim
pubmed-article:1356567lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:1356567lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:1356567lifeskim:mentionsumls-concept:C0082264lld:lifeskim
pubmed-article:1356567lifeskim:mentionsumls-concept:C0857121lld:lifeskim
pubmed-article:1356567pubmed:issue4lld:pubmed
pubmed-article:1356567pubmed:dateCreated1992-11-20lld:pubmed
pubmed-article:1356567pubmed:abstractText1. The haemodynamic effects of dicentrine, an aporphine derivative isolated from the plant Lindera megaphylla, were investigated and compared with prazosin in rats. 2. In anaesthetized normotensive Wistar-Kyoto (WKY) rats, i.v. administration of dicentrine (0.1, 0.5, 1.0 mg kg-1) and prazosin (0.01, 0.05, 0.1 mg kg-1) induced a dose-related reduction of mean arterial pressure (MAP) which reached a maximal effect 5-10 min after injection and persisted for 2 h. 3. In anaesthetized WKY rats, a higher dose of dicentrine (1.0 mg kg-1, i.v.) did not cause any significant changes in heart rate (HR), cardiac output (CO) and stroke volume (SV) but markedly increased tail blood flow. In contrast, a higher dose of prazosin (0.1 mg kg-1, i.v.) produced a decrease in HR which paralleled the time course of the hypotensive response. 4. The hypotensive activity of dicentrine was completely abolished by alpha-adrenoceptor blockade. Both dicentrine and prazosin significantly attenuated pressor responses to noradrenaline but failed, even at maximal hypotensive doses, to impair the pressor effects of angiotensin II or vasopressin. These observations suggest that dicentrine appears to exert its hypotensive action through alpha 1-adrenoceptor blockade. 5. In conscious normotensive and spontaneously hypertensive (SH) rats, dicentrine (0.5-2.0 mg kg-1, i.v.) and prazosin (0.05-0.2 mg kg-1, i.v.) also evoked dose-related decreases in MAP which were of greater magnitude in SH rats. Oral administration of dicentrine (5 and 8 mg kg-1) to conscious SH rats caused a hypotensive effect which persisted for over 15 h.6. These results suggest that dicentrine may have therapeutic potential as an oral antihypertensive drug via alpha-adrenoceptor blockade.lld:pubmed
pubmed-article:1356567pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1356567pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1356567pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1356567pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1356567pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1356567pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1356567pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1356567pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1356567pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1356567pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1356567pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1356567pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1356567pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1356567pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1356567pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1356567pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1356567pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1356567pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1356567pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1356567pubmed:languageenglld:pubmed
pubmed-article:1356567pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1356567pubmed:citationSubsetIMlld:pubmed
pubmed-article:1356567pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1356567pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1356567pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1356567pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1356567pubmed:statusMEDLINElld:pubmed
pubmed-article:1356567pubmed:monthAuglld:pubmed
pubmed-article:1356567pubmed:issn0007-1188lld:pubmed
pubmed-article:1356567pubmed:authorpubmed-author:HuangT FTFlld:pubmed
pubmed-article:1356567pubmed:authorpubmed-author:ChenC CCClld:pubmed
pubmed-article:1356567pubmed:authorpubmed-author:TengC MCMlld:pubmed
pubmed-article:1356567pubmed:authorpubmed-author:HsuS YSYlld:pubmed
pubmed-article:1356567pubmed:authorpubmed-author:HuangY LYLlld:pubmed
pubmed-article:1356567pubmed:authorpubmed-author:YiS YSYlld:pubmed
pubmed-article:1356567pubmed:authorpubmed-author:LUF SFSlld:pubmed
pubmed-article:1356567pubmed:issnTypePrintlld:pubmed
pubmed-article:1356567pubmed:volume106lld:pubmed
pubmed-article:1356567pubmed:ownerNLMlld:pubmed
pubmed-article:1356567pubmed:authorsCompleteYlld:pubmed
pubmed-article:1356567pubmed:pagination797-801lld:pubmed
pubmed-article:1356567pubmed:dateRevised2010-9-7lld:pubmed
pubmed-article:1356567pubmed:meshHeadingpubmed-meshheading:1356567-...lld:pubmed
pubmed-article:1356567pubmed:meshHeadingpubmed-meshheading:1356567-...lld:pubmed
pubmed-article:1356567pubmed:meshHeadingpubmed-meshheading:1356567-...lld:pubmed
pubmed-article:1356567pubmed:meshHeadingpubmed-meshheading:1356567-...lld:pubmed
pubmed-article:1356567pubmed:meshHeadingpubmed-meshheading:1356567-...lld:pubmed
pubmed-article:1356567pubmed:meshHeadingpubmed-meshheading:1356567-...lld:pubmed
pubmed-article:1356567pubmed:meshHeadingpubmed-meshheading:1356567-...lld:pubmed
pubmed-article:1356567pubmed:meshHeadingpubmed-meshheading:1356567-...lld:pubmed
pubmed-article:1356567pubmed:meshHeadingpubmed-meshheading:1356567-...lld:pubmed
pubmed-article:1356567pubmed:meshHeadingpubmed-meshheading:1356567-...lld:pubmed
pubmed-article:1356567pubmed:meshHeadingpubmed-meshheading:1356567-...lld:pubmed
pubmed-article:1356567pubmed:year1992lld:pubmed
pubmed-article:1356567pubmed:articleTitleHaemodynamic effects of dicentrine, a novel alpha 1-adrenoceptor antagonist: comparison with prazosin in spontaneously hypertensive and normotensive Wistar-Kyoto rats.lld:pubmed
pubmed-article:1356567pubmed:affiliationPharmacological Institute, College of Medicine, National Taiwan University, Taipei.lld:pubmed
pubmed-article:1356567pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1356567pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:1356567pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1356567lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1356567lld:pubmed